Fresenius | FRE - Equity Capital And Reserves



Fresenius reported EUR18.94B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Akzo Nobel EUR 4.17B 452M Jun/2025
Alcon AG USD 22.13B 111M Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
BASF EUR 32.36B 3.73B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Beiersdorf EUR 8.47B 7M Jun/2025
DaVita Healthcare Partners USD -369633000 102.53M Jun/2025
Demant DKK 9.4B 168M Jun/2025
E.ON EUR 23.82B 5.11B Jun/2025
Essilor EUR 37.82B 3.18B Jun/2025
Fresenius EUR 18.94B 465M Jun/2025
Fresenius Medical Care EUR 14.33B 1.18B Jun/2025
Getinge SEK 33.01B 2.75B Dec/2024
Givaudan CHF 4.31B 320M Jun/2024
GlaxoSmithKline GBP 14.35B 197M Jun/2025
GN Store Nord DKK 10.45B 304M Jun/2025
GRIFOLS EUR 7.6B 1.96B Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.26B 1.64B Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Philips EUR 10.38B 1.32B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
RWE EUR 33.46B 1.91B Mar/2025
Sanofi 70.28B 3.8B Jun/2025
Smith & Nephew USD 5.54B 271M Jun/2025